Back | Next |
home / stock / rhhby / rhhby message board
Subject | By | Source | When |
---|---|---|---|
Breaking News: $RHHBY Genentech Presents New Data From | whytestocks | investorshub | 09/19/2020 2:30:14 PM |
Roche Holdings Ltd A ($RHHBY) | mick | investorshub | 09/18/2020 12:04:30 PM |
whytestocks: $RHHBY News Article - New Data Further Reinforce Genentech's Ocrevus (ocrelizumab) as a | whytestocks | investorshangout | 09/11/2020 5:35:46 PM |
Roche Holdings Ltd A ($RHHBY) | mick | investorshub | 09/05/2020 8:42:45 PM |
$rhhby $43.78 v -0.03 (-0.07%) | Taurus69 | investorshub | 09/05/2020 6:53:14 AM |
New article including Roche | Nfixus | investorshub | 08/31/2020 7:54:04 PM |
Hey mick if you like $RHHBY then you | pennypauly | investorshub | 08/25/2020 10:21:29 PM |
A Perfect Storm for Psychedelics Investors | MustBeTheTruth | investorshub | 08/24/2020 4:24:43 PM |
Roche Holdings Ltd A ($RHHBY) | mick | investorshub | 08/15/2020 5:19:12 PM |
$rhbby $43.1 v -1.29 (-2.91%) | Taurus69 | investorshub | 08/01/2020 6:57:42 PM |
$RHHBY Roche Holdings Ltd A ($RHHBY) | mick | investorshub | 07/25/2020 7:32:17 PM |
$rhhby $45.48 ^ 0.55 (1.22%) | Taurus69 | investorshub | 07/19/2020 5:28:57 PM |
$rhbby $44.12 ? 0.51 (1.17%) | Taurus69 | investorshub | 07/08/2020 11:51:40 PM |
Roche Holdings Ltd A ($RHHBY) | mick | investorshub | 06/30/2020 7:48:39 PM |
$rhbby $43.9 v -0.82 (-1.83%) | Taurus69 | investorshub | 06/27/2020 7:40:22 PM |
Roche Holdings Ltd A ($RHHBY) | mick | investorshub | 06/14/2020 4:36:06 AM |
Hopefuly | Tamtam | investorshub | 06/13/2020 11:04:24 PM |
Maybe a bottom here | Golden Cross | investorshub | 06/13/2020 12:28:05 PM |
$rhhby $42.95 v -0.35 (-0.81%) | Taurus69 | investorshub | 06/06/2020 10:51:38 AM |
Roche Holdings Ltd A ($RHHBY) | mick | investorshub | 05/28/2020 5:25:29 AM |
News, Short Squeeze, Breakout and More Instantly...
Roche Holding Ltd ADR Company Name:
RHHBY Stock Symbol:
OTCMKTS Market:
Wednesday, HOOKIPA Pharma Inc (NASDAQ:HOOK) received clearance from the FDA for its Investigational New Drug (IND) application for H...
– Results from the Phase III study showed that subcutaneous (SC) injection was consistent with IV infusion and demonstrated near-complete suppression of relapse activity (97%) and MRI lesions (97.2%) through 48 weeks – – The twice-yearly, 10-minute SC injection has th...
Monday, Roche Holdings AG (OTC:RHHBY) announced topline data from Phase 3 STARGLO study of Columvi (glofitamab) in combination ...